BUSINESS BioSyent Releases Financial Results for Fourth Quarter and Full Year 2025 Thursday, March 19, 2026 · globe newswire Advertisement Read Original Article → Related Dispatches [US] · Jun 18 Invesco S&P 500 Equal Weight Industrials ETF (NYSEARCA:RSPN) Sees Large Growth in Short Interest [CA] · Jun 18 Red Light Holland Reports Positive Preclinical Study Results for Coca in Weight Gain Prevention Post GLP-1 from Magdalena Biosciences, the Joint Venture Held Through Its Wholly Owned Subsidiary, Filament Health [EU] · Jun 18 As Anthropic CEO tells the world from G7 stage that democratic nations should come together to safeguard AI, here's the 'big truth' he seemingly forgot
